Bone Marrow Transplantation in Hurler syndrome - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Bone Marrow Transplantation in Hurler syndrome

Description:

Histol normal liver, kidney, brain glial cells, no peripheral cell vacuolation. variable decrease neuronal vacuolation. marked vacuolation chondrocytes ... – PowerPoint PPT presentation

Number of Views:435
Avg rating:3.0/5.0
Slides: 34
Provided by: quee65
Category:

less

Transcript and Presenter's Notes

Title: Bone Marrow Transplantation in Hurler syndrome


1
Bone Marrow Transplantation in Hurler syndrome
2
Transplanted tissue
  • Bone Marrow
  • Immature cells - stem cells
  • White blood cells
  • Red blood cells
  • Platelets
  • Peripheral blood stem cells
  • Umbilical cord stem cells

3
Tissue typing or matching
  • Human leukocyte-associated antigens (HLA)
  • 25 chance of sibling match
  • 30-40 chance HLA matched sib or parent
  • Unrelated donors - 6 HLA and minor antigens

4
Bone Marrow Harvest
  • Under anaesthesia
  • Large needle into pelvis gt sternum
  • Blood and bone removed from sample
  • Cryopreservation
  • Donor side effects
  • Local tenderness
  • few days to 3-4 wks full recovery

5
Peripheral Stem Cell Harvest
  • Stem cells stimulated by Granulocyte colony
    stimulating factor, G-CSF
  • Blood removed via large vein
  • Machine separates the stem cells
  • Blood minus stem cells is returned via a second
    canula
  • Cryopreservation

6
Cord Blood Collection
  • Usually compatability known from prenatal testing
  • Blood collected from cord after cord cut.
  • Stem cells separated in laboratory
  • Cryopreservation
  • (3/16 chance sib matching unaffected 1/16
    matching and not affected or carrier)

7
Daria and her donor, Caleb
8
The transplant
  • Conditioning patients own marrow obliterated
    with chemotherapy
  • Marrow or Stem cell Infusion donor cells infused
    via vein
  • Engraftment - donor cells enter marrow and start
    dividing 10-21 days
  • Close medical supervision 3 months
  • Long term follow-up

9
Jack after insertion of portocath
10
Infusion of Marrow
11
Complications of BMT
  • Death
  • Side effects of chemotherapeutic drugs (Nausea,
    vomiting, fatigue, loss of appetite, mouth
    ulcers, hair loss and skin reaction)
  • Infections (viral, bacterial and fungal)
  • Bleeding

12
Jack during Conditioning
13
Complications of BMT
  • Graft rejection
  • Acute graft versus host disease, GVHD (Skin rash
    liver disease gastrointestinal disturbance
    fever oedema)
  • Chronic GVHD (skin, liver, eyes, mouth, lungs,
    gastrointestinal system, nervous system

14
Hair like my Dad
15
Complications of BMT
  • Veno-occlusive disease blocking veins draining
    liver
  • Lung complications infection, GVHD, drugs, fluid
  • Mucositis ulceration mouth and gut
  • Transfusions red cells and platelets (donors
    blood group).

16
Jacks Isolation Room
17
Complications of BMT
  • Seizures / convulsions haemorrhage, clot, high
    blood pressure, infection, drugs
  • Haemorrhagic cystitis drugs or infection
  • Hypertension drugs
  • Dental problems infection, loss of enamel

18
Jack and his support team
19
Late Complications of BMT
  • Endocrine of hormone dysfunction - growth,
    puberty, energy
  • Infertility
  • Lung complications fibrosis
  • Eye disease cataract dry eyes
  • Kidney dysfunction
  • Secondary malignancy

20
Benefits of BMT for MPS 1H
  • Maintenance of IQ
  • Correction of hydrocephalus
  • Improved hearing
  • Normalised heart function
  • Normalisation size of liver and spleen
  • Survival

21
Jaime post BMT
22
Persisting problems after BMT for MPS 1H
  • Skeletal changes
  • Only partial correction corneal clouding
  • Progression of retinal disease
  • Heart valve changes
  • Carpal tunnel syndrome

23
Jaime 11yrs post BMT
24
BMT - Mechanisms
  • Bone marrow cells produce the microglial cells of
    the CNS
  • Enzyme transfer between cells (spleen, liver,
    lung, skin )
  • Release of enzyme into plasma - then taken up by
    host cell (wont cross BBB)
  • Concentration gradient storage product

25
Determinants of Survival GVHD
  • Matched siblinggtmatched relatedgt matched
    unrelated donor
  • Regime of irradiation and chemotherapy used

26
Determinants of Neuropsychological Outcome
  • Age lt 24 months
  • IQ gt 70
  • Donor not a carrier gt donor a carrier
  • ? Severity of GVHD

27
Psychosocial Aspects
  • Limited time to decide whether or not to have BMT
  • Decision period while still coming to terms with
    diagnosis
  • High risk of losing child in their best years
  • Disruption to family
  • Outcome data lags changes in regimes

28
Daria pre BMT
29
The Future
  • BMT ERT
  • Continually improving regimes

30
Jaime 11 yrs post BMT
31
(No Transcript)
32
(No Transcript)
33
Animal studies - BMTMPS-IH (Hurler)
  • Dog, cat and mouse
  • enzyme activity CSF 7-15 donor
  • Histol normal liver, kidney, brain glial cells,
    no peripheral cell vacuolation
  • variable decrease neuronal vacuolation
  • marked vacuolation chondrocytes
Write a Comment
User Comments (0)
About PowerShow.com